Enasidenib Can Cause Serious Symptoms in Some With Leukemia Enasidenib Can Cause Serious Symptoms in Some With Leukemia

A substantial minority of patients with relapsed or refractory acute myeloid leukemia (AML) show potentially deadly symptoms after treatment with enasidenib, according to a new analysis of data from an open-label trial.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news